TrialBritish journal of cancer2006

Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide.

J Cebon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.